Substantial evidence indicates that stress serves as a major risk factor for various psychiatric disorders, including major depressive disorder (MDD), anxiety disorders, post-traumatic stress disorder (PTSD), and bipolar disorder. Although multiple therapeutic options exist for these conditions, current treatments often fall short of meeting clinical needs. Since the identification of trace amine-associated receptor 1 (TAAR1), studies across diverse animal models have revealed its involvement in modulating stress responses and its potential role in stress-related psychopathologies. Several selective TAAR1 agonists have shown promising efficacy in alleviating certain stress-induced adverse effects. While the underlying mechanisms remain incompletely understood, emerging evidence suggests they may involve TAAR1 expression in key brain regions regulating stress, as well as its modulatory effects on neurotransmitter systems – such as dopamine, serotonin, and glutamate. This chapter summarizes current research on TAAR1, with a focus on the role of TAAR1 ligands in stress-related disorders. Additionally, we briefly discuss TAAR1-related signaling pathways in stress regulation and the pharmacology of TAAR1 agonists.